Healthcare
Nutex Health, Inc.(NUTX)
Live Price
Offline$144.40
-1.78% today
Window Change
+16.31%
Window
May 29, 2026 โ Jun 22, 2026
- Market Cap
- $830.00M
- Revenue Growth
- +82.4%
- EPS Growth
- +8.8%
- Dividend Yield
- 0.0%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 16 bars ยท May 29, 2026 โ Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Nutex Health, Inc. (NUTX) is a Healthcare stock with a market cap of $830.00M and listed on NASDAQ. The stock last traded around $144.40 and up 16.3% across the available one-year price window (May 29, 2026 โ Jun 22, 2026). Baseline metrics include revenue growth of +82.4%, EPS growth of +8.8%, a dividend yield of 0.0%. What stands out right now is revenue +82.4%, EPS +8.8%, free cash flow +1077.9% with operating margin 31.4% and ROIC 26.6%. Valuation is more restrained than many high-expectation growth names at P/E 9.7 and price/sales 0.9. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines NUTX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+82.4% vs +7.6% peer median
Operating Margin
Above sector median
+31.4% vs +19.4% peer median
P/E
Below sector median
9.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 4, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +82.4% and EPS at +8.8%, with operating margin around 31.4%.
Benchmark Edge
NUTX vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NUTX
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NUTX Max Drawdown
-3.16%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for NUTX and SPY.
Company Overview
Nutex Health, Inc.
NASDAQ Capital Market
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
- Leadership
- Thomas T. Vo
- IPO Date
- Apr 4, 2022
- Employees
- 800
- Street Address
- 6030 South Rice Avenue
- Mailing
- Houston, TX, 77081
- Region
- Houston, TX, US
- Reporting Currency
- USD
- Investor Line
- 713 660 0557
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 9.7
- EV/EBITDA
- 3.4
- Price/Sales
- 0.9
- Price/Book
- 2.1
Growth
- Revenue
- +82.4%
- EPS
- +8.8%
- Free Cash Flow
- +1077.9%
Profitability
- Gross Margin
- 47.5%
- Operating Margin
- 31.4%
- Net Margin
- 11.0%
- ROE
- 29.1%
- ROIC
- 26.6%
Balance Sheet
- Debt/Equity
- 0.73
- Current Ratio
- 3.14
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.